Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: Post hoc analysis of the ellipse trial.

Megan M OberleEric M BombergCarolyn T BramanteT V S DivyalasyaPaula M HaleChethana K RameshKyle D RudserAaron S Kelly

Published in: Pediatric obesity (2021)

Compared with placebo, liraglutide was associated with statistically significant reductions in BMI/weight parameters at week 52, but not week 26, in children and adolescents with T2D.

Keyphrases

body mass index
weight gain
phase iii
weight loss

physical activity
placebo controlled
study protocol

clinical trial
phase ii
double blind

body weight
randomized controlled trial
combination therapy